Lab Innovations – the UK’s only dedicated showcase for laboratory technology, analytical and biotech equipment – returns for its sixth consecutive year on 1& 2 November 2017 at the NEC, Birmingham.
With the largest gathering of laboratory suppliers in the UK, this free-to-attend show has lots on offer for professionals across a wide range of sectors, from pharmaceuticals to food and drink. Lab Innovations continues its strong links with the scientific community....
Waters Collaborates With IonSense on Direct Analysis for Mass Detection Waters and IonSense Exploring the Possibilities Enabled by Coupling the IonSense DART Source to the Waters ACQUITY QDa Mass Detector
Waters Corporation (NYSE:WAT) have announced a collaborative engagement with IonSense (Saugus, Mass.) to interface the compact Waters® ACQUITY® QDa® Mass Detector with the IonSense® DART® ionization source....
SepSolve Analytical has announced a change in its business operations that greatly expand its capability to offer full instrument packages to the analytical chemistry community, with a focus on two-dimensional gas chromatography (GC×GC) for challenging applications.
Founded in early 2016, SepSolve was originally launched to offer advice on sampling, separation and detection methodologies for GC and GC×GC analysis. Since that time, SepSolve’s GC×GC flow modulator, INSIGHT™....
Leaders in NGS tools collaborate to deliver robust multiplexing capabilities and streamline target enrichment methods
Integrated DNA Technologies (IDT) have announced a broad partnership with Illumina, Inc. to provide improved library preparation multiplexing and target enrichment solutions for the next generation sequencing (NGS) market....
Dr Graeme Clark PHD has joined Concept Life Sciences Dundee as Director of Analytical Services and DMPK.
Concept Life Sciences offers tailored preclinical services in areas including investigative and mechanistic toxicology, exploratory and discovery toxicology, PK and metabolism and dermal absorption, as well as providing integrated drug discovery programs....
Strategic commercial partnership in key European markets
SpeeDx Pty, Ltd. today announced an agreement with Cepheid for distribution of its PlexPCRTM and ResistancePlusTMmolecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK, will increase coverage for the market-leading ResistancePlus MG test, the first CE-IVD test for Mycoplasma genitalium to combine detection with testing for azithromycin resistance....
Oxford Gene Technology (OGT), The Molecular Genetics Company, today announced that it has signed an agreement to be acquired by Sysmex Corporation (Sysmex), a Japanese in vitro diagnostic company.
Sysmex will acquire all of OGT’s shares, gaining access to OGT’s genetic analysis technologies and expertise in the cytogenetics domain. OGT will become a wholly owned subsidiary of Sysmex. Further terms of the agreement are not being disclosed....
Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, has announced an agreement with Nova Biomedical (Nova), a well-known US manufacturer of cell culture analyzers, to integrate their BioProfile® FLEX2 into the ambr® multi-parallel bioreactor systems for automated, at-line cell culture analytics.
SSB and Nova are collaborating to combine two highly innovative technologies. Both the BioProfile® FLEX2 analyzer and the parallel bioprocessing functionality of the ambr® create a unique tool able to simultaneously run, sample and analyze a massive number of cell culture conditions during high-throughput cell line, media and process development by Design of Experiments (DoE).
Read MoreBigneat Wins Major Accolade: The QueenJun 22, 2017
Bigneat Ltd has been announced winner of a Queen’s Award for Enterprise 2017 – the UK’s highest accolade for business success.
Bigneat, an established manufacturer and leading provider of safety cabinets, hoods and enclosures for science and industry, has been awarded the Queen’s Award for International Trade in recognition of its Outstanding Short Term Growth in overseas sales over the past three years....
Besides branches in Singapore, Russia, China and France now FRITSCH opened its first subsidiary in the US: Fritsch Milling and Sizing Inc.
For a long time we have been serving customers in the USA but in order to meet the demands of our customers in a growing market it was time to have a FRITSCH branch directly in the US. The new FRITSCH Headquarters USA is located in North Carolina and is part of the so called “Research Triangle” consisting of numerous research institutes, established companies as well as renowned universities....
Science World, the Fisher Scientific Laboratory Experience, broadened its audience in Germany by going to Kap Europa, Messe Frankfurt on 9 May.
The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through the Fisher Scientific channel. Thousands of products were available for attendees to experience, making it an ideal event for anyone working in or around a laboratory....
Cloud-based imaging technology delivers compliant results without typical human bias
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced the acquisition of ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center. The acquisition enables ERT to offer advanced, end-to-end clinical trial imaging analysis using best-in-class technology that delivers compliant data for use in clinical development. “After conducting an exhaustive industry search...
ATUM (formerly DNA2.0, Inc.) announced today that the company has signed a patent licensing agreement that gives Thermo Fisher Scientific access to the company’s novel gene design platform. "Most people think visually, so seeing a graphic representation of a sequence is very helpful in the design process,” said Alan Villalobos...
The Native Antigen Company (NAC) announce that it has relocated into larger facilities, in Oxfordshire, UK
The new building has purpose-built laboratories and doubles the Company’s manufacturing capacity. This will increase the speed of new product development within NAC’s core business of infectious disease antigens and antibodies. The new laboratory space also enables NAC to add custom immunoassays to its offering to support customer’s ELISA assay and lateral flow device requirements....
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of a full range of chemistry testing services.
Offered by its subsidiary BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs). The service platform methods have been developed to ensure rapid sample analysis and reporting for mAbs and biosimilars....
Analytik are pleased to announce their appointment as exclusive distributors for Nanophoton, Japanese manufacturers of innovative, benchtop Raman imaging systems for both industrial and research laboratories.
Nanophoton is a manufacturer of high performance analytical and imaging instruments with major focus on innovative Raman systems by using most up-to-date photonics and nanotechnology. Nanophoton’s instruments include high performance Raman Imaging Systems, fast Raman Screening Systems...
King Abdullah University of Science and Technology (KAUST) and Thermo Fisher Scientific Inc. held an opening ceremony on May 9 for the Electron Microscopy Center of Excellence at the KAUST campus in Thuwal, Saudi Arabia.
This new center builds upon the long-standing partnership between KAUST and Thermo Fisher, and will focus on excellence in instrument performance and R&D collaboration. The Center of Excellence aims to offer KAUST scientists and collaborators exploration and experimentation capabilities through Thermo Fisher’s leading electron microscopy platform...
Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, announces the availability of its new fully synthetic, human Fab fragment library.
An announcement was made at the 13th annual PEGS meeting in Boston, MA by Guy Hermans, Isogenica’s CSO, who commented: “This novel fully synthetic antibody library, built using the company’s DNA library synthesis method (COLIBRA™), takes advantage of the most up to date understanding of the human antibody repertoire. Combining massive sequence diversity and dispersity with high functionality and developability, it offers the most efficient route to...
Powder characterisation specialists, Freeman Technology, continues to expand their global presence with the establishment of an operation in Japan and the appointment of Takashi Nishimura as Product Manager.
Based in Kobe City, Mr Nishimura has over 10 years of experience working in the analytical instrumentation industry and will provide sales and customer support in the region....
MR Solutions will be showing their latest state of the art 3T to 9.4T superconducting, cryogen-free MRI imaging technology with optional PET and SPECT imaging modalities at the 16th annual World Preclinical Congress in Boston.
The congress focusses on the very latest trends and technologies impacting the preclinical drug discovery and development world. MR Solutions’ preclinical imaging systems are revolutionising drug discovery by providing better scanners with a more viable footprint by doing away with all the equipment and building modifications required for liquid helium cooled machines....
ResistancePlus™ MG Test would bring disease and antibiotic resistance testing for potential “superbug”
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement with Thermo Fisher Scientific, the world leader in serving science. The announcement was made at the 27thEuropean Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna
Read MoreWellcome Trust Backs Dundee and GSK in Quest to find new Drugs for Neglected DiseasesMay 30, 2017
The University of Dundee has been awarded £7.9 million by the Wellcome Trust for a joint project with GSK to boost efforts to find new drugs to treat some of the world’s most devastating parasitic diseases including visceral and cutaneous leishmaniasis, and Chagas’ disease.
These neglected diseases cause substantial suffering and an estimated 60,000 deaths annually world-wide. The funding will enable the established Dundee/GSK team to continue their work to develop novel drugs to treat these diseases over the next five years....